HI HB1181

Reduces workers' compensation prescription drug reimbursement rate from 140% to 101% of average wholesale price, aligning Hawaii closer to national standards.

Requires injured employees and physicians to execute a written opioid therapy informed consent agreement if treatment exceeds three months, involves concurrent benzodiazepine use, or exceeds 90 morphine equivalent doses.

Limits reimbursement for Schedule II controlled substances to an initial seven-day supply per physician visit, with exceptions requiring informed consent process compliance.

Directs the Department of Health's harm reduction services branch to develop a template informed consent agreement addressing overdose risks, naloxone co-prescribing, non-opioid alternatives, functional goals, risk screening, drug testing, and prescription accountability system checks.

Restricts physician-dispensed prescription drugs to an unspecified period following injury and caps compounded prescription drug reimbursement at $1,000 per 30-day period with specific billing requirements.